Santam Chakraborty
Kolkata, WB, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Consensus Building for Radiotherapy Quality Assurance: A Multicenter Methodological Narrative From India (Standardised Unified Radiotherapy Quality Assurance).
Journal: JCO global oncology
Published: July 29, 2026
Impact of ultrahypofractionated adjuvant regional nodal radiotherapy on patient-reported quality of life: the HYPORT adjuvant trial (NCT03788213).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 06, 2026
Patterns of anesthesia(AS) and analgesia(AG) practice in gynecological brachytherapy in India.
Journal: Brachytherapy
Published: October 12, 2025
NEO-HYPORT: does neoadjuvant radiotherapy improve breast cancer outcomes? An open label, randomised, parallel group, superiority trial to compare the disease-free survival following neoadjuvant versus adjuvant hypofractionated radiotherapy in breast cancer (NEO-HYPORT).
Journal: Trials
Published: September 07, 2024
The cost of cancer care in India requires careful reporting and interpretation.
Journal: The Lancet regional health. Southeast Asia
Published: January 31, 2024
Enhancing quality assurance in radiotherapy for gynaecological cancers: implementation of an on-demand peer review process.
Journal: The British journal of radiology
Published: August 29, 2023
18F-fluorodeoxyglucose PET-CT-guided pelvic chemoradiation therapy using helical tomotherapy for locally advanced carcinoma cervix without para-aortic nodal disease: Clinical and patient-reported outcomes from a prospective phase 2 study.
Journal: Journal of medical imaging and radiation oncology
Published: August 21, 2023
ICON-P - A double-blind evaluation of quality improvements with individualized CONstraints from low-cost knowledge-based radiation therapy planning in prostate cancer.
Journal: Technical innovations & patient support in radiation oncology
Published: December 01, 2022
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 21, 2022
Last Updated: 09/26/2026